Resmed Inc. buy JPMorgan Chase & Co.
Start price
09.10.23
/
50%
€138.70
Target price
09.10.24
-
Performance (%)
56.31%
End price
10.10.24
€216.80
Summary
This prediction ended on 10.10.24 with a price of €216.80. With a performance of 56.31% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.82 was paid as dividends for this prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.781% | 2.781% | 5.805% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten